RESOURCES FOR PATIENTS AND CAREGIVERS
Be Prepared For Your Next Doctor’s Visit
Talking with your doctor on a continual basis is very important. Furthermore, it is important to keep your doctor informed of how you are feeling and your treatment progress. Take a few minutes to think about any questions or topics that you may want to bring up during your office visit. Here is a list of questions/topics you may have about ARIMIDEX for HR+ breast cancer.
- Why do I need ARIMIDEX, and how does it work to treat my breast cancer?
- What other treatment options are there?
- What are the differences between each option?
- Why is ARIMIDEX the option you've selected for me?
- How can I best prepare myself to start treatment?
- When should I start taking ARIMIDEX, and what is the length of treatment?
- How do I take ARIMIDEX, how often, and what is the dosage?
- What are the possible side effects of ARIMIDEX?
- How long after I start treatment can I expect to experience side effects, and how long can I expect them to last?
- What can I do to manage any side effects I may have?
- Is there a risk of recurrence while I'm on treatment or after my treatment ends?
- What is the follow-up plan after my treatment ends?
- Where can I find more information about the treatment you are recommending? What resources are available to me?
Need a reminder?
You can also download and print this Doctor Discussion Guide so you don’t have to remember everything. There's even space for you to write your own questions and to take notes as you and your doctor discuss your treatment.
Download the Guide
Learn about the stages of and treatments for breast cancer as well as how to find the support that you need.
Some Breast Cancer Basics
View Prescribing Information
Learn More About ARIMIDEX
Important Safety Information About ARIMIDEX
- Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child. Do not take ARIMIDEX if you are allergic to any of its ingredients
- Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen
- ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%)
- In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported
- In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache
- In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and weakness, pain, back pain, headache, bone pain, increased cough, shortness of breath, sore throat, and swelling of arms and legs. Joint pain/stiffness has been reported in association with the use of ARIMIDEX
- ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies
Approved Uses for ARIMIDEX
ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.
ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.
For more information, see your doctor.
Please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
This site is intended for US consumers only.
The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about ARIMIDEX, talk to your doctor or pharmacist. Only you and your health care professional can decide if ARIMIDEX is right for you.